Cancer

Shutting off inflammationA new way to curb inflammatory cells could lead to treatments for diseases including atherosclerosis and cancer.

Jacks appointed to cancer advisory board

Killing a cancer cell from the inside outSynthetic biologists design a gene circuit that, when delivered to cancer cells, forces them to commit suicide.

Ultrasensitive particles offer new way to find cancerTiny particles that measure microRNA levels in tissue samples could help diagnose and monitor many diseases.

Tumor cells go against the flowMicrofluidic model helps explain how fluid’s flow in bodily tissue influences tumor cell migration.

New lung cancer gene foundCancer biologists identify a driving force behind the spread of an aggressive type of lung cancer.

Study explains why men are at higher risk for stomach cancerMIT researchers show how estrogen protects women from the gastric inflammation that can lead to cancer.

Biologists discover how yeast cells reverse agingThe gene they found can double yeast lifespan when turned on late in life.

Working in harmonyMIT-designed nanoparticles communicate with each other inside the body to target tumors more efficiently.'

Turning off cancer’s growth signalsBiological engineers’ new approach to shutting down cell division could lead to new cancer drugs.

Removable ‘cloak’ for nanoparticles helps them target tumorsNew MIT particles could be used to deliver cancer drugs to nearly any type of tumor.

Understanding why lung cancer spreadsMIT biologists pinpoint a genetic change that helps tumors move to other parts of the body.

Catching cancer with carbon nanotubesNew device to test blood can spot cancer cells, HIV on the fly

In vivo systems biologyUsing computer models, systems biologists can predict complicated behavior of cells in living animals

The past, present and future of cancerResearchers gather to discuss the state of their field and the potential for new treatments.

David H. Koch Institute for Integrative Cancer Research fetedMIT celebrates the official opening of the institute's new building.

Going with the flowNew 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.

Exploiting cancer cells' weaknessesTeam identifies potential drugs that enhance stress caused by too many chromosomes.

Nano-sized vaccinesNew MIT nanoparticles could lead to powerful vaccines for HIV and other diseases.

Detecting whether a heart attack has occurredNew implantable sensor finds telltale signs; technology could also be adapted to monitor cancer and other diseases.

Vander Heiden wins cancer innovation awardAwarded $450,000 grant over three years

Putting up a struggle against cancerBlood-vessel cells can combat aggressive tumors, helping to prevent them from spreading through the body, new study finds.

Delivering a potent cancer drug with nanoparticles can lessen side effectsThe new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.

A new approach to bladder-disease treatmentImplanted device can release slow, steady dose of medicine over extended period, removing the need for repeated procedures.

Timing is everything for cancer protein p53Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.

Slideshow: the Koch Institute transforms East Campus environsCompletion of cancer-research building opens green space for community use and creates vibrant streetscape.

Direct deliveryCancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.

Using the body’s own defenses to combat cancerBy engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.

Turning off cancer genesRNA interference holds much promise as a cancer treatment, but technical challenges remain.

A better way to target tumorsIn spite of slow progress toward targeting cancer drugs to individual patients, hope remains.